As of May 30, 2026, CG Oncology's top three insider holders are Hong Fang Song (Director, 5.84Mn shares), Capital Global Life Sciences Fund Iv, L.P. Decheng (TenPercentOwner, 4.96Mn shares), Brian Guan-Chyun Liu (Director, 1.52Mn shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Capital Global Life Sciences Fund Iv, L.P. Decheng | - | 4,958,810 | 0 | 09 Apr, 2024 |
| Corleen M. Roche | Cfo Secretary | 2,000 | 0 | 31 Jan, 2024 |
| Arthur Kuan | Chief Executive Officer | 198,916 | 0 | 13 Mar, 2026 |
| Vijay Kasturi | Chief Medical Officer | 1,315 | 0 | 31 Jan, 2024 |
| Brian Guan-Chyun Liu | - | 0 | 1,515,151 | 12 Sep, 2025 |
| Hong Fang Song | - | 0 | 5,838,167 | 04 Sep, 2025 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 17 Apr, 2026 | James Mulay | Common Stock | A | 15,600 | $36.63 | 15,600 | D | M |
| 17 Apr, 2026 | James Mulay | Common Stock | D | 15,600 | $73.01 | 0 | D | S |
| 17 Apr, 2026 | James Mulay | Director Stock Option (right to buy) | D | 15,600 | $0.00 | 0 | D | M |
| 15 Apr, 2026 | James M. Detore | Employee Stock Option (Right to Buy) | A | 90,574 | $0.00 | 90,574 | D | A |
| 15 Apr, 2026 | Arthur Kuan | Employee Stock Option (Right to Buy) | A | 271,600 | $0.00 | 271,600 | D | A |
| 15 Apr, 2026 | Ambaw Bellete | Employee Stock Option (Right to Buy) | A | 107,508 | $0.00 | 107,508 | D | A |
| 15 Apr, 2026 | Joshua F. Patterson | Employee Stock Option (Right to Buy) | A | 45,266 | $0.00 | 45,266 | D | A |
| 15 Apr, 2026 | Arthur Kuan | Employee Stock Option (Right to Buy) | A | 271,600 | $0.00 | 271,600 | D | A |
| 15 Apr, 2026 | Vijay Kasturi | Employee Stock Option (Right to Buy) | A | 79,216 | $0.00 | 79,216 | D | A |
| 15 Apr, 2026 | Arthur Kuan | Employee Stock Option (Right to Buy) | A | 271,600 | $0.00 | 271,600 | D | A |
| 16 Mar, 2026 | James Mulay | Common Stock | A | 654 | $3.72 | 654 | D | M |
| 16 Mar, 2026 | James Mulay | Common Stock | D | 654 | $63.50 | 0 | D | S |
| 16 Mar, 2026 | James Mulay | Common Stock | A | 1,310 | $12.59 | 1,310 | D | M |
| 16 Mar, 2026 | James Mulay | Common Stock | D | 1,310 | $63.50 | 0 | D | S |
| 16 Mar, 2026 | James Mulay | Director Stock Option (right to buy) | D | 654 | $0.00 | 654 | D | M |
| 16 Mar, 2026 | James Mulay | Director Stock Option (right to buy) | D | 1,310 | $0.00 | 3,930 | D | M |
| 12 Mar, 2026 | Arthur Kuan | Common Stock | A | 64,612 | $1.72 | 200,763 | D | M |
| 12 Mar, 2026 | Arthur Kuan | Common Stock | A | 64,612 | $1.72 | 200,763 | D | M |
| 12 Mar, 2026 | Arthur Kuan | Common Stock | A | 64,612 | $1.72 | 200,763 | D | M |
| 12 Mar, 2026 | Arthur Kuan | Common Stock | A | 64,612 | $1.72 | 200,763 | D | M |